indazoles has been researched along with Tongue Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kleszcz, R; Paluszczak, J | 1 |
| Akashi, K; Arita, S; Ariyama, H; Baba, E; Jiroumaru, R; Kusaba, H; Nakano, T; Nio, K; Oda, Y; Tsuchihashi, K; Yasumatsu, R; Yoshihiro, T | 1 |
| Hirabayashi, T; Tachibana, T; Takahashi, H; Watanabe, M | 1 |
3 other study(ies) available for indazoles and Tongue Neoplasms
| Article | Year |
|---|---|
The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells.
Topics: Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cell Survival; Deoxyglucose; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Indazoles; Pyrimidinones; Tongue; Tongue Neoplasms; Wnt Signaling Pathway | 2022 |
Lingual alveolar soft part sarcoma responsive to pazopanib: A case report.
Topics: Antineoplastic Agents; Humans; Indazoles; Male; Pyrimidines; Sarcoma, Alveolar Soft Part; Sulfonamides; Tongue Neoplasms; Treatment Outcome; Young Adult | 2017 |
Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.
Topics: Aged, 80 and over; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Keratin-13; Keratin-17; Ki-67 Antigen; Lymphatic Metastasis; Mice, SCID; Tongue Neoplasms; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2017 |